POLARx Post Approval Study (POLARx PAS)
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Na · None · Treatment
Enrollment
200actual
Sites
11
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-06-28 | actual | When the study began enrolling |
| Primary completion | 2026-05-20 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-05-20 | actual | The whole study's end, after follow-up |
| First posted | 2023-12-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Paroxysmal Atrial Fibrillation
Intervention
- Device: Boston Scientific Cardiac Cryoablation System
Primary outcomes
what the primary-completion date above is the date OFPercentage of Participants With Freedom From Primary Safety Events at 12 Months Post-procedure (Acute and Chronic Events) Using the Boston Scientific Cardiac Cryoablation System With POLARx Cryoablation Balloon Catheter Models
measured 12 Months
Percentage of Participants With Freedom From Treatment Failure at 12 Months Post-procedure Using the Boston Scientific Cardiac Cryoablation System With POLARx Cryoablation Balloon Catheter Models
measured 12 Months
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed